<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Crocin is a water-soluble <z:chebi fb="2" ids="23044">carotenoid</z:chebi> isolated from the Crocus sativus L (saffron) stigma </plain></SENT>
<SENT sid="1" pm="."><plain>It has previously been reported that it has protective effects against renal, cardiac, and global cerebral ischemic injury </plain></SENT>
<SENT sid="2" pm="."><plain>However its therapeutic effects remain to be clarified regarding ischemic reperfusion injuries, <z:hpo ids='HP_0002181'>brain edema</z:hpo>, and activity of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzymes in a transient model of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was induced by 60-minute middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), followed by 23-hour reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>Crocin at doses of 15, 30, 60, and 120 mg/kg intraperitoneally were injected at the start of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume and neurologic outcome were evaluated 24 hours after MCAO </plain></SENT>
<SENT sid="6" pm="."><plain>For the therapeutic time window measurement, crocin (60 mg/kg) was given 1, 3, and 6 hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>; 24 hours later <z:hpo ids='HP_0002181'>brain edema</z:hpo> and <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme activity were assessed </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The results indicated that treatment with crocin at doses of 30, 60, and 120 mg/kg significantly decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by 64%, 74%, and 73%, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>Administration of crocin (60 mg/kg) 1 hour before, at the start, or 1 hour after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> reduced <z:hpo ids='HP_0002181'>brain edema</z:hpo> by 48%, 52%, and 51%, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, crocin (60 mg/kg) significantly reduced malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) content and increased activity of <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD) and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase (GPx) in the ischemic cortex (P&lt; .001) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Our findings indicate that crocin has protective effects against ischemic reperfusion injury and <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> in a rat model of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>These effects of crocin may have been exerted primarily by suppression of the production of free radicals and increased <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme activity </plain></SENT>
</text></document>